Tandem Diabetes Care
TNDM
303 hedge funds and large institutions have $5.47B invested in Tandem Diabetes Care in 2020 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 80 increasing their positions, 116 reducing their positions, and 40 closing their positions.
98% more call options, than puts
Call options by funds: $134M | Put options by funds: $67.7M
63% more first-time investments, than exits
New positions opened: 65 | Existing positions closed: 40
52% more capital invested
Capital invested by funds: $3.6B → $5.47B (+$1.87B)
13% more funds holding in top 10
Funds holding in top 10: 8 → 9 (+1)
9% more funds holding
Funds holding: 279 → 303 (+24)
1.65% less ownership
Funds ownership: 93.78% → 92.12% (-1.7%)
31% less repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 116
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$65.3M |
| 2 |
Millennium Management
New York
|
+$60.8M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$46.2M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$36.3M |
| 5 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$34.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$81M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$56.7M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$43.9M |
| 4 |
State Street
Boston,
Massachusetts
|
-$40M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$33.6M |
TNDM Hedge Fund Activity: Q2 2020 in Review
303 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q2 2020, worth a combined $5.47B — up 52% from $3.6B a quarter earlier.
Buyers outnumbered sellers: 65 funds opened new TNDM positions and 40 closed out — a net gain of 25 holders — while 80 added to existing stakes and 116 trimmed.
The largest buyer was Capital World Investors, opening a new position worth an estimated $65.3M. The largest seller was BlackRock, cutting an estimated $81M.
- 303 institutional investors held Tandem Diabetes Care (TNDM) as of Q2 2020, up from 279 in Q1 2020.
- Funds reported $5.47B of Tandem Diabetes Care stock for Q2 2020, up 52% quarter-over-quarter.
- 65 funds opened new Tandem Diabetes Care positions in Q2 2020 and 40 closed out, a net change of +25 holders.
- The largest Tandem Diabetes Care buyer in Q2 2020 was Capital World Investors, an estimated $65.3M added.
- The largest Tandem Diabetes Care seller in Q2 2020 was BlackRock, an estimated $81M sold.
Based on aggregated 13F filings for Q2 2020.